The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Open accessAbstract
Activation of nuclear factor (NF)-κB, one of the most investigated transcription factors, has been found to control multiple cellular processes in cancer including inflammation, transformation, proliferation, angiogenesis, invasion, metastasis, chemoresistance and radioresistance. NF-κB is constitutively active in most tumor cells, and its suppression inhibits the growth of tumor cells, leading to the concept of ‘NF-κB addiction’ in cancer cells. Why NF-κB is constitutively and persistently active in cancer cells is not fully understood, but multiple mechanisms have been delineated including agents that activate NF-κB (such as viruses, viral proteins, bacteria and cytokines), signaling intermediates (such as mutant receptors, overexpression of kinases, mutant oncoproteins, degradation of IκBα, histone deacetylase, overexpression of transglutaminase and iNOS) and cross talk between NF-κB and other transcription factors (such as STAT3, HIF-1α, AP1, SP, p53, PPARγ, β-catenin, AR, GR and ER). As NF-κB is ‘pre-active’ in cancer cells through unrelated mechanisms, classic inhibitors of NF-κB (for example, bortezomib) are unlikely to mediate their anticancer effects through suppression of NF-κB. This review discusses multiple mechanisms of NF-κB activation and their regulation by multitargeted agents in contrast to monotargeted agents, thus ‘one size does not fit all’ cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–230 of 230
Inhibition of NF-κB Acetylation and its Transcriptional Activity by Daxx
Park, J., Lee, J. H., La, M., Jang, M. J., Chae, G. W., Kim, S. B., Tak, H., Jung, Y., Byun, B., Ahn, J. K., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.047 · Cited by 61
C/EBPβ Blocks p65 Phosphorylation and Thereby NF-κB-Mediated Transcription in TNF-Tolerant Cells
Zwergal, A., Quirling, M., Saugel, B., Huth, K. C., Sydlik, C., Poli, V., Neumeier, D., Ziegler‐Heitbrock, H. W. L., & Brand, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.665 · Cited by 61
Kleinberg, L., Dong, H. P., Holth, A., Risberg, B. Å., Tropé, C. G., Nesland, J. M., Flørenes, V. A., & Davidson, B. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.10.019 · Cited by 58
NF-κB controls growth of glioblastomas/astrocytomas
Smith, D. L., Shimamura, T., Barbera, S., & Bejcek, B. E. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9593-4 · Cited by 57
TGF-β downregulates PTEN via activation of NF-κB in pancreatic cancer cells
Chow, J. Y. C., Ban, M., Wu, H. L., Nguyen, F., Huang, M. J., Chung, H., Dong, H., & Carethers, J. M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2009 · Cited by 55
Mosialos, G., & Td, G. (1993) · PubMed · Cited by 53
Extending the nuclear roles of IκB kinase subunits
Gloire, G., Dejardin, E., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.017 · Cited by 52
Bijli, K. M., Fazal, F., Minhajuddin, M., & Rahman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802094200 · Cited by 51
Over-expression of Flt3 induces NF-κB pathway and increases the expression of IL-6
Takahashi, S., Harigae, H., Ishii, K. K., Inomata, M., Fujiwara, T., Yokoyama, H., Ishizawa, K., Kameoka, J., Licht, J. D., Sasaki, T., et al. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.01.008 · Cited by 50
Copine-I represses NF-κB transcription by endoproteolysis of p65
Ramsey, C. S., Yeung, F., Stoddard, P. B., Li, D., Creutz, C. E., & Mayo, M. W. (2008) · Oncogene · doi:10.1038/sj.onc.1211030 · Cited by 46
MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation
Nawata, R., Yujiri, T., Nakamura, Y., Ariyoshi, K., Takahashi, T., Satō, Y., Oka, Y., & Tanizawa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206901 · Cited by 45
NF-κB as a therapeutic target in chronic lymphocytic leukemia
López‐Guerra, M., & Colomer, D. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003598930 · Cited by 45
Vatsyayan, J., Qing, G., Xiao, G., & Hu, J. (2008) · EMBO Reports · doi:10.1038/embor.2008.122 · Cited by 42
Grosjean-Raillard, J., Adès, L., Boehrer, S., Tailler, M., Fabre, C., Braun, T., de Botton, S., Israël, A., Fenaux, P., & Kroemer, G. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0243-4 · Cited by 39
Kai, M., Yasuda, S., Imai, S.-I., Toyota, M., Kanoh, H., & Sakane, F. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.017 · Cited by 37
Toualbi, K., Bleiberg-Daniel, F., Guller, M. C., Legrand, A., Mauriz, J. L., Mauviel, A., & Bernuau, D. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm293 · Cited by 35
Grosjean-Raillard, J., Adès, L., Boehrer, S., Tailler, M., Fabre, C., Braun, T., de Botton, S., Israël, A., Fenaux, P., & Kroemer, G. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1154-9 · Cited by 34
Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer
Kim, S.-P., Park, J., Lee, S.-H., Lim, J. H., Jang, B., Lee, S., Jang, I.-H., Freund, J., Suh, S., Mun, K. C., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.020 · Cited by 33
NF-κB as a Prognostic Marker and Therapeutic Target in Chronic Lymphocytic Leukemia
Pepper, C. J., Hewamana, S., Brennan, P., & Fegan, C. (2009) · Future Oncology · doi:10.2217/fon.09.72 · Cited by 33
Dhawan, P., Su, Y., Thu, Y. M., Yu, Y., Baugher, P. J., Ellis, D. L., Sobolik-Delmaire, T., Kelley, M., Cheung, T. C., Ware, C. F., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708272200 · Cited by 32
Ishinaga, H., Jono, H., Lim, J. H., Komatsu, K., Xu, X., Lee, J., Woo, C.-H., Xu, H., Feng, X., Chen, L., et al. (2008) · Biochemical Journal · doi:10.1042/bj20080781 · Cited by 29
Tago, K., Funakoshi‐Tago, M., Sakinawa, M., Mizuno, N., & Itoh, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117028 · Cited by 28
Hyperoxia-induced NF-κB activation occurs via a maturationally sensitive atypical pathway
Wright, C. J., Zhuang, T., La, P., Yang, G., & Dennery, P. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90499.2008 · Cited by 28
Inhibitor-κB Kinase in Tumor Promotion and Suppression During Progression of Squamous Cell Carcinoma
Waes, C. V., Yu, M., Nottingham, L. K., & Karin, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1287 · Cited by 28
Braunstein, S. E., Formenti, S. C., & Schneider, R. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0339 · Cited by 27
Accumulation of phosphorylated IκBα and activated IKK in nodes of Ranvier
Politi, C., Turco, D. D., Sie, J. M., Golinski, P., Tegeder, I., Deller, T., & Schultz, C. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00901.x · Cited by 24
Targeting mitogen-activated protein kinase kinase (MEK) in solid tumors
Duffy, A. G., & Kummar, S. (2009) · Targeted Oncology · doi:10.1007/s11523-009-0125-x · Cited by 22
Inflammatory Tales of Liver Cancer
Hoffmann, A., Xia, Y., & Verma, I. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.008 · Cited by 17
Fan, Y., Mao, R., Zhao, Y., Yu, Y., Sun, W., Song, P., Shi, Z., Zhang, D., Yvon, E. S., Zhang, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018994 · Cited by 17
Grosjean, J., Adès, L., Boehrer, S., Fenaux, P., & Kroemer, G. (2007) · Blood · doi:10.1182/blood.v110.11.2434.2434 · Cited by 15
Cited by
Liu, B., Sun, L., Liu, Q., Gong, C., Yao, Y., Lv, X., Lin, L., Yao, H., Su, F., Li, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.004 · Cited by 908
C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., Thiruvenkatam, R., et al. (2014) · Nature · doi:10.1038/nature13109 · Cited by 670
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Metadata
- Authors
- Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B.
- Venue
- Oncogene
- Published
- 2010-12-20
- Volume
- 30
- Issue
- 14
- Pages
- 1615-1630
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2038713860
- Cited by
- 473
- References
- 230
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.